Abstract
In conclusion, disseminated strongyloidiasis is a fatal disease that commonly affects the lungs. The disease should be suspected in an immunocompromised host who came from an area endemic for S stercoralis even years before the onset of symptoms or in patients with unexplained gram-negative bacteremia or meningitis. Treatment should be started promptly and should be maintained for a long time.
MeSH terms
-
Acquired Immunodeficiency Syndrome / complications*
-
Adult
-
Aged
-
Aged, 80 and over
-
Animals
-
Bronchoalveolar Lavage Fluid / parasitology*
-
Bronchopneumonia / complications*
-
Bronchopneumonia / immunology
-
Bronchopneumonia / parasitology
-
Humans
-
Immune Tolerance*
-
Larva / isolation & purification
-
Male
-
Middle Aged
-
Prognosis
-
Sputum / parasitology*
-
Strongyloides / isolation & purification
-
Strongyloidiasis / complications*
-
Strongyloidiasis / diagnosis
-
Strongyloidiasis / drug therapy
-
Strongyloidiasis / immunology
-
Thiabendazole / therapeutic use